The gross politicizing of the COVID 19 pandemic has crippled the relevant process of scientific dialogue and exploration leaving us without a shred of alignment as to how best to treat this disease and pinning far too much hope on the vaccination process. There are important insights regarding the use of existing treatments like ivermectin and hydrochloroquine and infrared photobiomodulation that are not being taken seriously enough here in the USA while other countries are saving lives and decreasing the disasterous effects of lockdowns on the economy. Quietmind is working with Durham University and other research groups to better understand the use of PBM for treating CV19 symptoms and helping to prevent infection by boosting immune responsiveness. Take this article seriously and prepare your own lines of defense against this terrible disease.
This is a new paper that we think helps to clarify how photobiomodulation should be viewed as an adjunctive or combination therapy. Its use as a way to activate biochemical and nanoparticle-based therapeutics is a direct pairing of noninvasive and more invasive therapeutic strategies. We have studied, validated and are now combining PBM with neurofeedback and TDCS/TACS for dementing illnesses as well as movement disorders and traumatic brain injuries. This is definitely the beginning of what will be growing trend as Pharma expands its position in both digital neurotherapeutics and electroceuticals.
There's been a fair amount of discussion recently about frequency enhanced water and how it may assist in healing and immune system protection etc. I found this video to be a good introduction to the basic concepts involved in the transformation of water when it is exposed to electromagnetic energy. The absorption of EM energy across a wide frequency band suggests that water may transmit or resonate with frequencies in our body in useful ways. See what you think and do share your thoughts here in the comment section.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.